Lexicon Pharmaceuticals, Inc. (LXRX)
1.995
-0.02
(-1.24%)
USD |
NASDAQ |
Sep 11, 14:42
Lexicon Pharmaceuticals Gross Profit (TTM) : 40.63M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 40.63M |
| March 31, 2026 | 68.74M |
| December 31, 2025 | 48.91M |
| September 30, 2025 | 69.82M |
| June 30, 2025 | 57.35M |
| March 31, 2025 | 30.03M |
| December 31, 2024 | 29.93M |
| September 30, 2024 | 4.335M |
| June 30, 2024 | 2.786M |
| March 31, 2024 | 1.609M |
| December 31, 2023 | 0.566M |
| September 30, 2023 | 0.006M |
| June 30, 2023 | -0.067M |
| March 31, 2023 | -0.304M |
| December 31, 2022 | -0.288M |
| September 30, 2022 | -0.213M |
| June 30, 2022 | -0.144M |
| March 31, 2022 | -0.072M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 5.517M |
| March 31, 2021 | 13.55M |
| December 31, 2020 | 20.48M |
| September 30, 2020 | 28.00M |
| June 30, 2020 | 315.84M |
| Date | Value |
|---|---|
| March 31, 2020 | 315.65M |
| December 31, 2019 | 316.89M |
| September 30, 2019 | 325.46M |
| June 30, 2019 | 37.99M |
| March 31, 2019 | 42.58M |
| December 31, 2018 | 58.74M |
| September 30, 2018 | 74.73M |
| June 30, 2018 | 94.65M |
| March 31, 2018 | 93.22M |
| December 31, 2017 | 86.44M |
| September 30, 2017 | 54.35M |
| June 30, 2017 | 28.53M |
| March 31, 2017 | 17.53M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Viatris, Inc. | 5.838B |
| Pfizer Inc. | 41.30B |
| ANI Pharmaceuticals, Inc. | 505.18M |
| Corcept Therapeutics, Inc. | 816.73M |
| Veru, Inc. | -0.113M |